|
Project detail:
The project involves expansion of the existing manufacturing unit for synthetic organic chemicals, including Active Pharmaceutical Ingredients (APIs) and intermediates, through the addition of three adjoining plots (Nos. 106, 107 and 108). The proposed product range includes Folic Acid, Caffeine, Theobromine, Theophylline, Propyphenazone, Rivaroxaban and R&D products, alongside existing products. The overall production capacity after expansion will be 513.7 MT/month. The report states that the expansion supports product quality, research and development, and customer requirements. It is expected to provide employment and trade opportunities, benefit local people and contractors, and contribute tax revenue.
Project Cost: ?78.66 crore (proposed expansion cost). Total project investment, including the existing unit, is stated as ?99.35 crore.
Note: please download project document attached to this project for more information
|
